Latest Als News

Bayan Mining and Minerals has begun a third phase of surface sampling at its Bayan Springs South gold project in Nevada, extending an open southern anomaly and testing a previously unsampled northern fault intersection. The work is intended to sharpen drill targets, while assays from the company’s completed Desert Star RC program are expected in October 2026.

Viking Mines has identified several wide zones of visually confirmed scheelite in ongoing RC drilling at its Linka tungsten project in Nevada, including 22 metres across a 24-metre horizon. The encouraging visual results remain unassayed, leaving laboratory results as the next critical test of grade and continuity.

Minrex Resources has completed its 33-hole Barje infill program and begun a 6,604-metre greenfield campaign at Tlamino in Serbia. The drilling will test whether Barje and Liska form part of a single mineralised system extending more than 1.5 kilometres.

Kaili Resources has reported a peak one-metre assay of 1,125.51 ppm total rare earth oxides from shallow aircore drilling at its Coodalya tenement in South Australia. The result adds to an emerging zone of elevated values, but the early-stage program has not yet established continuity, scale or economic significance.

Neurizon will redeem 1 million convertible notes held by Obsidian for US$1.15 million, while securing a two-month standstill on share sales. The biotechnology company says the transaction leaves it funded through the HEALEY ALS trial readout and completion.

A multimillion-dollar, multiyear NIH grant will fund an expanded access program for Neurizon’s investigational NUZ-001, potentially giving up to 200 US patients access to the therapy for as long as 96 weeks. The program is designed to add long-term safety, survival and biomarker data alongside the pivotal HEALEY ALS trial.

ActivEX has identified preliminary rare earth element anomalies across an 8km soil grid at its Aramac Project in Queensland, including 28 samples above 1,000ppm TREE. The readings come from handheld pXRF analysis and must be confirmed by laboratory assays now pending from ALS.

Neurizon has appointed Dr Chris Bremer as chief executive as its NUZ-001 ALS program moves towards topline Phase 2/3 results expected in late Q2 2027. The incoming CEO brings more than 20 years of pharmaceutical and biotechnology experience, including over US$1 billion in licensing transactions.

Hawsons Iron has confirmed its ability to upgrade magnetite concentrate to a premium 69.3% iron grade through bulk-scale elutriation testwork, significantly reducing impurities and enhancing potential revenue streams.

Eclipse Metals' latest testwork confirms that up to 94% of neodymium and praseodymium are locked in identifiable REE minerals at Grønnedal, underpinning a promising beneficiation strategy ahead of flotation trials.

AusQuest’s latest diamond drilling at the Cangallo project in Peru pushes copper mineralisation down to at least 800 metres and reveals multiple higher-grade zones, reinforcing the scale of this emerging porphyry system.

Hawsons Iron Limited’s latest bulk elutriation testwork upgraded its magnetite concentrate from 67.8% to 69.3% iron, slashing impurities and reinforcing the project’s premium product potential.